$13.520
-0.853 (-6.31%)收盘时
TRXB 同业对比
In the context of the broader market, TRXB competes directly with industry leaders such as RZLT and AVTX. With a market capitalization of $396.04M, it holds a significant position in the sector. When comparing efficiency, TRXB's gross margin of N/A stands against RZLT's N/A and AVTX's N/A. Such benchmarking helps identify whether TRex Bio, Inc. is trading at a premium or discount relative to its financial performance.
TRex Bio, Inc. Common stock 财务表现
The financial metrics show a P/E ratio of 0 and a forward P/E of 0, suggesting no earnings expectations. The EV to EBITDA is negative at -8.61, indicating potential issues with profitability.
Financials
No data
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。